New insight into how the immune system sounds the alarm

August 3, 2015
The protein kinase ZAP-70 (green) clusters at the plasma membrane upon T cell activation. Credit: Salk Institute

T cells are the guardians of our bodies: they constantly search for harmful invaders and diseased cells, ready to swarm and kill off any threats. A better understanding of these watchful sentries could allow scientists to boost the immune response against evasive dangers (e.g., cancer or infections), or to silence it when it mistakenly attacks the body itself (e.g., autoimmune disorders or allergies).

Now, scientists at the Salk Institute have discovered that T cell triggering relies on a dynamic protein network at the cell surface, as reported in August 3, 2015, in Nature Immunology.

"This is a completely new principle for how T cell activity is controlled—whether it ignores or responds to a threat," says senior author Björn Lillemeier, an assistant professor in the Nomis Foundation Laboratories for Immunobiology and Microbial Pathogenesis and the Waitt Advanced Biophotonics Center at the Salk Institute.

T become active when a signal—often from a virus or bacterium—triggers molecular sensors on their surface, namely T cell receptors. Previously, scientists believed that additional molecules that bind T cell receptors and help it to perceive this signal were like grapes hanging from a vine, occasionally dropping away or joining to begin the process. In contrast, the new discovery shows that T cell receptors are incredibly active—more like a bustling train station, with molecules rapidly coming and going at different intervals of time, says Lillemeier, who is also the Helen McLoraine Developmental Chair.

A protein called ZAP-70 is well known as a crucial player for kicking the T cell into action. Until now, scientists assumed that a silent form of ZAP-70 floats around inside the T cell until a threat is detected, which recruits ZAP-70 to the cell surface and activates it. By analyzing mutant forms of ZAP-70, Lillemeier's group discovered that instead of ZAP-70 binding the T cell receptor firmly, it comes in contact with the receptor sporadically. Each time this happens, ZAP-70 has to adopt an unfavorable shape that forces it back inside the cell. This cycle continues until a second molecule, called Lck, helps it to remain with the T . The prolonged stay at the activates ZAP-70 and prompts the T cell to attack invaders and .

The video will load shortly
Scientists at the Salk Institute have discovered that T cell triggering relies on a dynamic protein network at the cell surface, as reported in August 3, 2015, in Nature Immunology. Credit: Salk Institute

This study shows that the steps underlying T cell activation are much more dynamic compared with the less mobile modes that scientists had suspected before. The new study highlights how ZAP-70 and other molecules communicate in space and time, which is crucial for controlling the ultimate activity of a T cell. By understanding this process, Lillemeier says, "We might be able to encourage the immune system to be a little more sensitive in order to recognize and eliminate diseases."

Lillemeier's team is working to identify new principles that determine if T cells respond to a threat versus staying quiet. In addition, they are testing whether their findings could be applied across additional processes in T cells and other immune cells. Because proteins have many of the same modular building blocks, in principle, any protein with structural characteristics comparable to those of ZAP-70 could be controlled by similar mechanisms, Lillemeier says.

Explore further: Crystal clear images uncover secrets of hormone receptors

Related Stories

Crystal clear images uncover secrets of hormone receptors

July 31, 2015

Many hormones and neurotransmitters work by binding to receptors on a cell's exterior surface. This activates receptors causing them to twist, turn and spark chemical reactions inside cells. NIH scientists used atomic level ...

Monoclonal antibody targets, kills leukemia cells

March 25, 2013

Researchers at the University of California, San Diego Moores Cancer Center have identified a humanized monoclonal antibody that targets and directly kills chronic lymphocytic leukemia (CLL) cells.

Toward more targeted cancer vaccines

February 17, 2015

Scientists from Cardiff have used powerful X-ray technology to visualise how white blood cells interact with skin cancer cells, paving the way for the development of more accurate cancer vaccines.

Recommended for you

Enzyme key to triggering anti-cancer immune response

June 27, 2017

An enzyme implicated in autoimmune diseases and viral infections also regulates radiation therapy's ability to trigger an immune response against cancer, Weill Cornell Medicine scientists found in a new study. Their discovery ...

Experts uncover first molecular events of organ rejection

June 23, 2017

Researchers at the University of Pittsburgh School of Medicine and the University of Toronto have uncovered the first molecular steps that lead to immune system activation and eventual rejection of a transplanted organ. The ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.